University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Assessment Of Vascular Health After Niacin Therapy (AVANT)

Not Applicable

Completed

Conditions: Coronary Artery Disease
Carotid Artery Disease
Peripheral Artery Disease

Interventions: Drug: Placebo
Drug: Niacin

First Posted Date: 2013-12-06

Last Posted Date: 2014-06-25

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 9

Registration Number: NCT02003638

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

EC17 for Intraoperative Imaging in Occult Ovarian Cancer

Phase 1

Completed

Conditions: Ovarian Cancer

Interventions: Drug: EC17

First Posted Date: 2013-12-04

Last Posted Date: 2018-06-04

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT02000778

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Way to Be Active I (Teams)

Not Applicable

Completed

Conditions: Sedentary Employees

Interventions: Behavioral: Individual Incentives
Behavioral: Team Incentives
Behavioral: Individual plus Team Incentives

First Posted Date: 2013-12-04

Last Posted Date: 2019-03-05

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 304

Registration Number: NCT02001194

FDG PET/CT in Breast Cancer Bone Mets

Active, not recruiting

Conditions: Estrogen Receptor Positive Breast Cancer
Bone Metastases

Interventions: Other: FDG PET/CT scan

First Posted Date: 2013-11-27

Last Posted Date: 2024-08-21

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 75

Registration Number: NCT01996046

Locations: 🇺🇸
University of Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

EC17 for Intraoperative Imaging for Parathyroidectomy

Phase 1

Completed

Conditions: Primary Hyperparathyroidism

Interventions: Drug: EC17

First Posted Date: 2013-11-27

Last Posted Date: 2018-07-03

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT01996072

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

BDNF Pregnancy Study

Completed

Conditions: Pregnancy

First Posted Date: 2013-11-25

Last Posted Date: 2015-06-01

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 32

Registration Number: NCT01992744

Locations: 🇺🇸
3701 Market Street, Philadelphia, Pennsylvania, United States
🇺🇸
Penn Medicine Washington Square (PMWS), Philadelphia, Pennsylvania, United States
🇺🇸
Penn Center for Women's Behavioral Wellness, Philadelphia, Pennsylvania, United States

and more 1 locations

Thromboelastography-derived Functional Fibrinogen Levels

Completed

Conditions: Focus of Study
Coagulation Status of Cardiac Surgery Patient
Reducing Excess Blood Transfusion

First Posted Date: 2013-11-25

Last Posted Date: 2018-10-03

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 51

Registration Number: NCT01992757

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Intraoperative Imagery of Breast Cancer With Folate-FITC (EC17)

Phase 1

Completed

Conditions: Resectable Breast Cancer

Interventions: Drug: EC17

First Posted Date: 2013-11-25

Last Posted Date: 2018-07-03

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT01994369

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Temporary Biventricular Pacing

Not Applicable

Completed

Conditions: Right Ventricular (RV) Dysfunction

Interventions: Other: left ventricular epicardial pacing lead

First Posted Date: 2013-11-19

Last Posted Date: 2017-11-14

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 2

Registration Number: NCT01987531

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy

Not Applicable

Withdrawn

Conditions: Planned RRSO

Interventions: Drug: Placebo
Drug: Estradiol
Drug: Lisdexamfetamine

First Posted Date: 2013-11-18

Last Posted Date: 2017-03-24

Lead Sponsor: University of Pennsylvania

Registration Number: NCT01986764

Locations: 🇺🇸
Penn Center for Women's Behavioral Wellness, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy